Igor Mrdović
YOU?
Author Swipe
View article: Long-Term Prognosis in Patients with ST-Elevation Myocardial Infarction Complicated by Heart Failure with Preserved Left Ventricular Ejection Fraction.
Long-Term Prognosis in Patients with ST-Elevation Myocardial Infarction Complicated by Heart Failure with Preserved Left Ventricular Ejection Fraction. Open
Development of in-hospital HFpEF in STEMI patients was an independent predictor for long-term mortality. The negative prognostic impact of HFpEF was weaker when compared to the impact of in-hospital HFrEF.
View article: Predictors of Major Adverse Cardiovascular Events in Stable Patients After ST Elevation Myocardial Infarction
Predictors of Major Adverse Cardiovascular Events in Stable Patients After ST Elevation Myocardial Infarction Open
Background/aim: The aim of this study was to determine predictors of major adverse cardiovascular events, including MACE (mortality, non-fatal recurrent infarction, non-fatal stroke, and target vessel revascularization-TVR) in stable post-…
View article: Long-Term Prognosis in Patients With St-Elevation Myocardial Infarction Complicated by Heart Failure with Preserved Left Ventricular Ejection Fraction
Long-Term Prognosis in Patients With St-Elevation Myocardial Infarction Complicated by Heart Failure with Preserved Left Ventricular Ejection Fraction Open
Background/aim: to analyze eight year mortality in patients with ST-elevation myocardial infarction (STEMI) complicated by the development of heart failure with preserved ejection fraction (HFpEF). Method: we analyzed 3260 STEMI patients t…
View article: Prognostic Value of the RISK-PCI Score in Patients with Non-ST-Segment Elevation Acute Myocardial Infarction
Prognostic Value of the RISK-PCI Score in Patients with Non-ST-Segment Elevation Acute Myocardial Infarction Open
Background: Non-ST-segment elevation acute myocardial infarction (NSTEMI) represents a heterogeneous patient population with varying risks of adverse outcomes. The RISK-PCI score, initially developed for ST-segment elevation myocardial inf…
View article: Long-Term Prognostic Impact of Stress Hyperglycemia in Non-Diabetic Patients Treated with Successful Primary Percutaneous Coronary Intervention
Long-Term Prognostic Impact of Stress Hyperglycemia in Non-Diabetic Patients Treated with Successful Primary Percutaneous Coronary Intervention Open
Background: stress hyperglicemia (SH) is common in patients with ST-elevation myocardial infraction (STEMI). The aims of this study were to analyze the impact of SH on the incidence of all-cause mortality and major adverse cardiovascular e…
View article: Long-Term Prognostic Impact of Insulin- and Non-insulin Treated Diabetes Mellitus in Patients With a Reduced Left Ventricular Ejection Fraction Following ST-Elevation Myocardial Infarction
Long-Term Prognostic Impact of Insulin- and Non-insulin Treated Diabetes Mellitus in Patients With a Reduced Left Ventricular Ejection Fraction Following ST-Elevation Myocardial Infarction Open
Background/aim: Insulin- and non-insulin treated diabetes (ITDM and NITDM) may have different prognostic impact in patients with ST-elevation myocardial infarction (STEMI) and /or heart failure. The aims of this study were to analyze the i…
View article: Prognostic Impact of Stress Hyperglycemia in Non-Diabetic Patients Treated with Successful Primary Percutaneous Coronary Intervention
Prognostic Impact of Stress Hyperglycemia in Non-Diabetic Patients Treated with Successful Primary Percutaneous Coronary Intervention Open
Background: Stress hyperglycemia (SH) is common is patients with ST-elevation myocardial infraction (STEMI). The aims of the study were to analyze the impact of SH on the incidence of all-cause mortality and major adverse cardiovascular ev…
View article: Long-Term Prognosis after ST-Elevation Myocardial Infarction in Patients with Premature Coronary Artery Disease
Long-Term Prognosis after ST-Elevation Myocardial Infarction in Patients with Premature Coronary Artery Disease Open
Background: A significant percentage of younger patients with myocardial infarction have premature coronary artery disease (CAD). The aims of this study were to analyze all-cause mortality and major adverse cardiovascular events (MACEs car…
View article: Long-Term Prognosis after St-Elevation Myocardial Infarction in Patients with Premature Coronary Artery Disease
Long-Term Prognosis after St-Elevation Myocardial Infarction in Patients with Premature Coronary Artery Disease Open
Background: A significant percentage of younger patients with myocardial infarction have premature coronary artery disease (CAD). The aims of this study were to analyze all-cause mortality and major adverse cardiovascular events (MACE- car…
View article: Prognostic Impact of Non-Cardiac Comorbidities on Long-Term Prognosis in Patients with Reduced and Preserved Ejection Fraction following Acute Myocardial Infarction
Prognostic Impact of Non-Cardiac Comorbidities on Long-Term Prognosis in Patients with Reduced and Preserved Ejection Fraction following Acute Myocardial Infarction Open
Background: We aimed to analyze the prevalence and long-term prognostic impact of non-cardiac comorbidities in patients with reduced and preserved left-ventricular ejection fraction (EF) following ST-elevation myocardial infarction (STEMI)…
View article: Prognostic Impact of Non-cardiac Comorbidities on Long-Term Prognosis in Patients with Reduced and Preserved Ejection Fraction Following Acute Myocardial Infarction
Prognostic Impact of Non-cardiac Comorbidities on Long-Term Prognosis in Patients with Reduced and Preserved Ejection Fraction Following Acute Myocardial Infarction Open
Background: The prognostic impact of non-cardiac comorbidities can vary in relation to the left ventricular ejection fraction (EF) in patients with ST-elevation myocardial infarction (STEMI). The aim was to analyze prevalence and long-term…
View article: Sudden cardiac death in long-term follow-up in patients treated with primary percutaneous coronary intervention
Sudden cardiac death in long-term follow-up in patients treated with primary percutaneous coronary intervention Open
Objective. Most studies analyzing predictors of sudden cardiac death (SCD) after acute myocardial infarction included only high-risk patients or index reperfusion had not been performed in all patients. The aim of our study was to analyze …
View article: The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis
The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis Open
Objective. The objective of this study is to analyze the impact of declining kidney function on the occurrence of the slow-flow/no-reflow phenomenon in patients with ST-elevation myocardial infarction (STEMI) treated with primary PCI (pPCI…
View article: Early and Late Mortality Predictors in Patients with Acute Aortic Dissection Type B
Early and Late Mortality Predictors in Patients with Acute Aortic Dissection Type B Open
Background/Aim. Despite technological advances in diagnosis and treatment, in-hospital mortality with acute aortic dissection type B is still about 11%. The purpose of this study was to assess the risk factors for early and long-term adver…
View article: Electromechanical Association as a Stemi Mimicry - Case Report
Electromechanical Association as a Stemi Mimicry - Case Report Open
Electromechanical association is a very unique physiological type of ECG artifact caused by the radial artery pulse tapping. ECG presentation of this artifact may imitate primary repolarization changes characteristic for acute coronary syn…
View article: Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era
Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era Open
The COVID-19 pandemic has led to numerous negative implications for all aspects of society. Although COVID-19 is a predominant lung disease, in 10–30% of cases, it is associated with cardiovascular disease (CVD). The presence of myocardial…
View article: Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation
Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation Open
The incidence of atrial fibrillation (AF) in acute coronary syndrome (ACS) ranges from 2.3–23%. This difference in the incidence of AF is explained by the different ages of the patients in different studies and the different times of appli…
View article: The impact of the complete atrioventricular block on in-hospital and long-term mortality in patients treated with primary percutaneous coronary intervention
The impact of the complete atrioventricular block on in-hospital and long-term mortality in patients treated with primary percutaneous coronary intervention Open
Background/Aim. The prognostic impact of complete atrioventricular (AV) block on the long-term prognosis of patients with ST-elevation myocardial infarction (STEMI) has not been fully determined. The aim of the study was to analyze the inc…
View article: Impact of kidney function on the occurrence of new-onset atrial fibrillation in patients with ST-elevation myocardial infarction
Impact of kidney function on the occurrence of new-onset atrial fibrillation in patients with ST-elevation myocardial infarction Open
Decreased kidney function was significantly associated with the occurrence of new-onset AF, and its impact increased with the deterioration in kidney function, starting with an eGFR value of 90 mL/min/m2. New-onset AF was an independent pr…
View article: The impact of complete atrioventricular block on in-hospital and long-term mortality in patients with ST-elevation myocardial infarction
The impact of complete atrioventricular block on in-hospital and long-term mortality in patients with ST-elevation myocardial infarction Open
Funding Acknowledgements Type of funding sources: None. Background/aim: Complete atrioventricular (AV) block is associated with worse in-hospital outcome in patients with ST-elevation myocardial infarction (STEMI), while whether it has an …
View article: Myocardial deformation imaging in early prediction of heart failure development after STEMI is better than conventional echocardiography: true or false?
Myocardial deformation imaging in early prediction of heart failure development after STEMI is better than conventional echocardiography: true or false? Open
Funding Acknowledgements Type of funding sources: None. onbehalf PREDICT-VT Heart failure (HF) still develops in 4% up to 28% of STEMI pts treated by pPCI, with the highest incidence in the first year. Accurate and early identification of …
View article: Can analysis of myocardial mechanic help me to predict heart failure development in my STEMI patient whose EF is equal or above 50% after pPCI?
Can analysis of myocardial mechanic help me to predict heart failure development in my STEMI patient whose EF is equal or above 50% after pPCI? Open
Funding Acknowledgements Type of funding sources: None. onbehalf PREDICT-VT In spite of contemporary STEMI management, heart failure (HF) develops in 4% up to 28% of pPCI-treated patients, with the highest incidence in the first year. Left…
View article: Left ventricular and left atrial deformation imaging early after pPCI: does diabetes mellitus make any difference?
Left ventricular and left atrial deformation imaging early after pPCI: does diabetes mellitus make any difference? Open
Funding Acknowledgements Type of funding sources: None. onbehalf PREDICT-VT More extensive coronary atherosclerosis in diabetes mellitu (DM) induces poorer clinical outcomes after STEMI, but there are data suggesting that impaired myocardi…
View article: Limitations of rapid serological testing for SARS-CoV-2 in non-vaccinated patients in acute cardiac care
Limitations of rapid serological testing for SARS-CoV-2 in non-vaccinated patients in acute cardiac care Open
In December 2019 in the city of Wuhan, in China, the first cases of infection caused by the new SARS-CoV-2 virus appeared, and later on, the disease caused by this virus was named COVID-19. Shortly after this, on March 11 th , 2020, the WH…
View article: The importance of early and late ventricular arrhythmias detection and prediction in acute myocardial infarction
The importance of early and late ventricular arrhythmias detection and prediction in acute myocardial infarction Open
Background Malignant arrhythmias, ventricular tachycardia or ventricular fibrillation (VT/VF) in acute myocardial infarction (AIM) carry ominous prognosis including sudden cardiac death (SCD). It is not clear whether the timing of VT/VF oc…
View article: P963 Heart failure development in patients with preserved ejection fraction after STEMI: how frequent is It and can we predict it?
P963 Heart failure development in patients with preserved ejection fraction after STEMI: how frequent is It and can we predict it? Open
Data regarding heart failure (HF) development among patients with preserved EF (≥50%) after STEMI are spare. Accurate and early identification of patients at risk might allow timely application of modern therapy targeted for HFpEF. Aim the…
View article: 570 Myocardial deformation imaging after STEMI: can we better predict one-year mortality and heart failure development?
570 Myocardial deformation imaging after STEMI: can we better predict one-year mortality and heart failure development? Open
Prognosis after STEMI is still challenging. One-year mortality ranges between 10-12% and the incidence of heart failure (HF) is between 4% and 28%. Early and accurate identification of high-risk patients necessitates therapy intensificatio…
View article: Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary Intervention
Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary Intervention Open
Background/Aim . The RISK-PCI is a simple score for the prediction of 30-day major adverse cardiovascular events (MACE) and mortality in patients treated with primary PCI (pPCI). The aim of the present study is to evaluate the prognostic p…
View article: Impact of Multivessel Coronary Artery Disease on Long Term Prognosis in Patients with ST-segment Elevation Myocardial Infarction
Impact of Multivessel Coronary Artery Disease on Long Term Prognosis in Patients with ST-segment Elevation Myocardial Infarction Open
Background: A significant proportion of patients with ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease (MVD), and they are at high risk for recurrent cardiac events. The aim of the present study w…